tween80 (MedChemExpress)
MedChemExpress is a verified supplier 
MedChemExpress manufactures this product 
99
Structured Review
MedChemExpress
tween80
Tween80, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 99/100, based on 425 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tween80/Tween+80/pmc12988229-40-0-2
Average 99 stars, based on 425 article reviews
Tween80, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 99/100, based on 425 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tween80/Tween+80/pmc12988229-40-0-2
Average 99 stars, based on 425 article reviews
tween80 - by Bioz Stars,
2026-10
99/100 stars
Images
Related Articles
Mouse Assay:Article Title: Targeting N 6 -methyladenosine demethylase FTO overcomes osimertinib resistance by inducing G0/G1 phase arrest in an m 6 A-dependent manner in lung adenocarcinoma. Article Snippet: Resistance to osimertinib, a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI), is a significant challenge for patients with advanced EGFR-mutant lung adenocarcinoma (LUAD).. Fat mass and obesity-associated protein (FTO), an N6-methyladenosine (m6A) demethylase, plays a critical role in the occurrence, metastasis, and drug resistance of various tumors.. We found that high FTO expression was significantly associated with resistance to osimertinib in advanced LUAD patients harboring EGFR mutations. Solvent:Article Title: Targeting N 6 -methyladenosine demethylase FTO overcomes osimertinib resistance by inducing G0/G1 phase arrest in an m 6 A-dependent manner in lung adenocarcinoma. Article Snippet: Resistance to osimertinib, a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI), is a significant challenge for patients with advanced EGFR-mutant lung adenocarcinoma (LUAD).. Fat mass and obesity-associated protein (FTO), an N6-methyladenosine (m6A) demethylase, plays a critical role in the occurrence, metastasis, and drug resistance of various tumors.. We found that high FTO expression was significantly associated with resistance to osimertinib in advanced LUAD patients harboring EGFR mutations. Saline:Article Title: Targeting N 6 -methyladenosine demethylase FTO overcomes osimertinib resistance by inducing G0/G1 phase arrest in an m 6 A-dependent manner in lung adenocarcinoma. Article Snippet: Resistance to osimertinib, a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI), is a significant challenge for patients with advanced EGFR-mutant lung adenocarcinoma (LUAD).. Fat mass and obesity-associated protein (FTO), an N6-methyladenosine (m6A) demethylase, plays a critical role in the occurrence, metastasis, and drug resistance of various tumors.. We found that high FTO expression was significantly associated with resistance to osimertinib in advanced LUAD patients harboring EGFR mutations. Article Title: Tumor innervation drives cancer cell plasticity and immune evasion through the SLPI-GZMB axis. Article Snippet: Peripheral nerves contribute to tumor progression, but the mechanisms by which neural signals regulate cancer cell plasticity and immune resistance remain unclear.. Using a paired murine model of intraneural and nonintraneural tumor growth with single-cell RNA sequencing, we identified a nerve-associated cancer cell state marked by increased expression of secretory leukocyte protease inhibitor (SLPI).. SLPI was elevated in intraneural tumors and in human tumors with perineural invasion. Article Title: Investigating the role of baseline gut Akkermansia muciniphila and its co-metabolite palmitoleic acid in BCG vaccine efficacy: a preclinical study Article Snippet: Destabilisation of the actin cytoskeleton of cells was conducted using 1 μM Cytochalasin D. To determine the effect of actin polymerisation induction in mice vaccinated with BCG, mice were concurrently injected with 20 nM jasplakinolide (MCE, HY-P0027) or vehicle. .. A stock solution of the compound was prepared by dissolving it in a vehicle consisting of 10% DMSO (D2650, Sigma Aldrich), 40% PEG300 (HY-Y0873, MCE), 5% Injection:Article Title: Targeting N 6 -methyladenosine demethylase FTO overcomes osimertinib resistance by inducing G0/G1 phase arrest in an m 6 A-dependent manner in lung adenocarcinoma. Article Snippet: Resistance to osimertinib, a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI), is a significant challenge for patients with advanced EGFR-mutant lung adenocarcinoma (LUAD).. Fat mass and obesity-associated protein (FTO), an N6-methyladenosine (m6A) demethylase, plays a critical role in the occurrence, metastasis, and drug resistance of various tumors.. We found that high FTO expression was significantly associated with resistance to osimertinib in advanced LUAD patients harboring EGFR mutations. |